1.Gastric Cancer Presenting as a Krukenberg Tumor at 22 Weeks' Gestation.
Paul Vincent CO ; Ashutosh GUPTA ; Bashar M ATTAR ; Melchor DEMETRIA
Journal of Gastric Cancer 2014;14(4):275-278
Gastric cancer is rare during pregnancy, and often advanced upon presentation. A Krukenberg tumor presents a diagnostic and therapeutic challenge in the pregnant patient. We present a case of a 38-year-old woman at 22 weeks' gestation who presented with worsening epigastric pain, and was found to have a left pelvic mass on ultrasound, which was confirmed by magnetic resonance imaging. She went into active labor and delivered a viable infant via vaginal delivery. An exploratory laparotomy revealed a large mass originating from her left ovary and diffuse thickening of the lesser curvature of the stomach. Frozen section investigation revealed the presence of signet cell adenocarcinoma. Subsequent upper endoscopy showed linitis plastica, while biopsy confirmed the presence of adenocarcinoma. In conclusion, the occurrence of gastric cancer in pregnancy is rare despite extremely common symptoms. The management poses a challenge because of the need for early treatment, and the continuation of the pregnancy.
Adenocarcinoma
;
Adult
;
Biopsy
;
Endoscopy
;
Female
;
Frozen Sections
;
Humans
;
Infant
;
Krukenberg Tumor*
;
Laparotomy
;
Linitis Plastica
;
Magnetic Resonance Imaging
;
Ovary
;
Pregnancy*
;
Stomach
;
Stomach Neoplasms*
;
Ultrasonography
2.Aspirin and clopidogrel resistance in Filipino patients with recurrent noncardioembolic ischemic strokes in a tertiary hospital: A cross-sectional study
Diana-Lynn Que ; Remy Margarette Berroya-Moreno ; Christian Oliver C. Co ; Peter Paul Dela Paz Rivera ; Vincent Paul E. De Guzman ; Ma. Cristina Macrohon-Valdez ; Lina C. Laxamana ; Manuel M. Mariano ; Maria Carissa C. Pineda-Franks
Philippine Journal of Neurology 2024;27(1):20-27
Background:
Antiplatelet resistance is one factor that contributes to stroke recurrence among patients with
noncardioembolic ischemic strokes.
Objectives:
This paper aims to describe the prevalence of aspirin and clopidogrel resistance, along with
frequency of statin, NSAID and proton pump inhibitor use among our cohort of stroke patients.
Method. This is a single-center cross-sectional review that included all adult patients with
recurrent noncardioembolic ischemic stroke admitted in a tertiary hospital between January
2019 and June 2023.
Results:
A total of 1,374 patients were admitted for ischemic stroke from January 2019 to June 2023.
Among these, 155 (11.28%) were recurrent noncardioembolic ischemic strokes. Prevalence of
aspirin and clopidogrel resistance were 25% and 32.7%, respectively. Clinical profiles of those in
the resistant group were comparable with those in the nonresistant group. None of the patients
taking aspirin had concomitant use of nonsteroidal antiinflammatory drugs. Only 2 of the
patients who were resistant to clopidogrel were on proton pump inhibitors. More than half of
the patients both in the resistant and the nonresistant groups were on statin. The study had a
small sample size and hence it was not enough to establish causal relationship between factors
and antiplatelet resistance.
Conclusion
More patients were resistant to clopidogrel than to aspirin. Further studies with a bigger sample
size are recommended to explore factors that contribute to antiplatelet resistance in Filipino
patients.
Aspirin
;
Clopidogrel
;
Ischemic Stroke
;
Tertiary Care Centers